Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aphex BioCleanse Systems's Enterprise Value is $0.03 Mil.
Aphex BioCleanse Systems does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Aphex BioCleanse Systems's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aphex BioCleanse Systems's Enterprise Value is $0.03 Mil.
Aphex BioCleanse Systems does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Aphex BioCleanse Systems's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aphex BioCleanse Systems's Enterprise Value is $0.03 Mil.
Aphex BioCleanse Systems does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Aphex BioCleanse Systems's EV-to-Revenue at this moment.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Aphex BioCleanse Systems's Enterprise Value is $0.03 Mil.
Aphex BioCleanse Systems does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Aphex BioCleanse Systems's EV-to-FCF at this moment.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Aphex BioCleanse Systems (OTCPK:SNST) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Aphex BioCleanse Systems Enterprise Value Related Terms
Aphex BioCleanse Systems Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aphex BioCleanse Systems Enterprise Value Chart
Aphex BioCleanse Systems Annual Data
Trend
Enterprise Value
Aphex BioCleanse Systems Quarterly Data
Enterprise Value
Aphex BioCleanse Systems Enterprise Value Competitor Comparison
For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aphex BioCleanse Systems Enterprise Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aphex BioCleanse Systems's Enterprise Value falls into.
Aphex BioCleanse Systems Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Aphex BioCleanse Systems's Enterprise Value for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aphex BioCleanse Systems (SNST) has a Enterprise Value of $0.03 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Enterprise Value too high?
Aphex BioCleanse Systems' current Enterprise Value is $0.03 Mil.
How does Aphex BioCleanse Systems' Enterprise Value compare to competitors?
Aphex BioCleanse Systems' Enterprise Value of $0.03 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aphex BioCleanse Systems and its competitors. Aphex BioCleanse Systems's current Enterprise Value is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Enterprise Value of $0.03 Mil. The current Enterprise Value is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Enterprise Value is $0.03 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNST has been successfully added to your